Danish company joins Ebola battle
Another Danish company has joined the ranks of global biopharma players aiming to develop a drug to combat the deadly Ebola virus.
BY STEFAN SINGH KAILAY
Bavarian Nordic is already making massive strides in its efforts to develop an Ebola vaccine in collaboration with Big Pharma and now, another Danish company is lending its support to the battle against the deadly virus.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
